SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-20-023789
Filing Date
2020-12-17
Accepted
2020-12-16 19:54:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 50010
  Complete submission text file 0001493152-20-023789.txt   51355
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81115 | Film No.: 201393877
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1801 CENTURY PARK EAST #1600 LOS ANGELES CA 90067
Business Address
Kovach John S (Filed by) CIK: 0001368556 (see all company filings)

Type: SC 13D/A